Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test new Drug's safety with common pills

NCT ID NCT06948747

Summary

This early-stage study tested how an experimental drug, AZD5004, interacts with several common medications, including cholesterol drugs (like atorvastatin) and a diabetes drug (repaglinide). It involved 49 healthy adult volunteers to see if taking AZD5004 changes how the body processes these other drugs, and vice versa. The main goal was to gather safety data and understand potential drug interactions before further testing in patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Research Site

    Brooklyn, Maryland, 21225, United States

Conditions

Explore the condition pages connected to this study.